🇺🇸 FDA

Intelligence Platform

Patents

Browse 1,166 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 10548970

Human rotavirus G9P[6] strain and use as a vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Feb 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10544392

Methods of isolating T cells and T cell receptors having antigenic specificity for a cance

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10543257

Lentiviral vector for treating hemoglobin disorders

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Jan 28 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jan 23 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10519222

Broadly neutralizing monoclonal antibodies against HIV-1 V1V2 Env region

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10517890

Triggering RNA interference with RNA-DNA and DNA-RNA nanoparticles

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 31 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10512671

IL-24 to treat inflammatory diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10512673

Use of peptide-based inhibitors of the stat3-IL10 pathway for treating bacterial infection

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10513521

Compositions and methods for inhibiting BMP

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 24 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 19 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10508106

Bicyclic BET bromodomain inhibitors and uses thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 17 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 12 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10500264

Development of mutations useful for attenuating dengue viruses and chimeric dengue viruses

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10500269

Human rotavirus vaccine strains and diagnostics

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10500238

Use of gram negative species to treat atopic dermatitis

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10501507

Griffithsin mutants

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Dec 10 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 05 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10485771

Methods of regulating cannabinoid receptor activity-related disorders and diseases

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10485792

Sustained release delivery systems for the prevention and treatment of head and neck cance

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10478415

Ketone bodies to protect tissues from damage by ionizing radiation

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10480031

Method for generating Retinal Pigment Epithelium (RPE) cells from Induced Pluripotent Stem

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 19 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 14 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10471061

Galactokinase inhibitors for the treatment and prevention of associated diseases and disor

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10472412

Bispecific multivalent fusion proteins

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 12 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 07 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10464970

Compounds that bind to human immunodeficiency virus rev response element

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Nov 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10456461

Construction of West Nile virus and dengue virus chimeras for use in a live virus vaccine

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 29 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 24 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10450372

Anti-thyroglobulin T cell receptors

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 22 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 17 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10434174

Combination therapies using platinum agents and agents that target tumor-associated stroma

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 08 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 03 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 10428314

Human ebola virus species and compositions and methods thereof

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Oct 01 2019 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Sep 26 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

granted